Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
5-Imidazol-1-ylmethyl-quinolin-8-ol
Potential treatment - theoretical effect Experimental Antiviral Jan/27/2021
gp96-Ig-S
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/26/2021
N-[(1R)-2-(Tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2021
Dolutegravir
Potential treatment - theoretical effect Used to treat other disease Antiviral Jan/25/2021
Tizoxanide
Potential treatment - theoretical effect Experimental Antiviral Jan/25/2021
Z-FA-FMK
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/24/2021
Lactoferrin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/23/2021
Heparin
Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021
Human amnionic fluid
Potential treatment - clinical evidence Experimental Other treatment Jan/22/2021
RBD-SpyVLP
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/22/2021
Pontacyl violet 6R
Potential treatment - theoretical effect Experimental Antiviral Jan/21/2021
Catechin-gallocatechin-catechin
Potential treatment - theoretical effect Natural product Antiviral Jan/21/2021
1-[1-(6-Chloroquinolin-4-yl)piperidin-4-yl]piperidin-3-ol
Potential treatment - theoretical effect Experimental Antiviral Jan/20/2021
(1R,2R)-2-N-(7-Chloroquinolin-4-yl)cyclohexane-1,2-diamine
Potential treatment - theoretical effect Experimental Antiviral Jan/20/2021
Ombitasvir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021
Micafungin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021
Tipranavir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021
Paritaprevir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021
Cov2-16
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
CoV2-09
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021